Who are Soligenix, Inc.'s main suppliers?

Soligenix, Inc. (SNGX) key suppliers include: NEW-YORK-UNIVERSITY, RODMAN, UBC, YEDA-RESEARCH-AND-DEVELOPMENT-COMPANY-LTD, GRTXD and 3 more. View the full supplier network at chainsifter.com/chain/SNGX.

Who are Soligenix, Inc.'s major customers?

Soligenix, Inc. (SNGX) key customers include: SCICLONE-PHARMACEUTICALS-INC. View the full customer network at chainsifter.com/chain/SNGX.

What sector is Soligenix, Inc. in?

Soligenix, Inc. (SNGX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

SNGX Supply Chain: Soligenix, Inc. Supplier List & 12 Relationships

8Suppliers

1Customers

3Debt Items

2Related Chains

Soligenix, Inc. Suppliers

Ticker	Name	Confidence	Evidence
NEW-YORK-UNIVERSITY	NEW-YORK-UNIVERSITY	90%	we acquired a worldwide exclusive license agreement with New York University and Yeda Research and Development Company Ltd. for the rights to a novel PDT that utilizes safe visible light for activation
RODMAN	RODMAN	90%	In January 2026, the Company entered into the Rodman Sales Agreement to sell shares of the Company’s common stock from time to time, through ATM sales.
UBC	UBC	90%	The license agreement with UBC provides us with exclusive worldwide rights to manufacture, distribute, market sell and/or license or sublicense products derived or developed from this technology.
YEDA-RESEARCH-AND-DEVELOPMENT-COMPANY-LTD	YEDA-RESEARCH-AND-DEVELOPMENT-COMPANY-LTD	90%	we acquired a worldwide exclusive license agreement with New York University and Yeda Research and Development Company Ltd. for the rights to a novel PDT that utilizes safe visible light for activation
GRTXD	GRTXD	72%	Reciprocal relationship from GRTXD graph: Reciprocal relationship from SNGX graph: Reciprocal relationship from GRTXD graph: Reciprocal relationship from SNGX graph: Reciprocal relationship from GRTX…
GRTXD	GRTXD	72%	urers of the drug substances is limited. In the event it is necessary or advisable to acquire supplies from alternative suppliers, assuming commercially reasonable terms could be reached, the challen…
IPHYF	IPHYF	72%	Reciprocal relationship from IPHYF graph: Reciprocal relationship from SNGX graph: Reciprocal relationship from IPHYF graph: Reciprocal relationship from SNGX graph: urers of the drug substances is l…
IPHYF	IPHYF	72%	urers of the drug substances is limited. In the event it is necessary or advisable to acquire supplies from alternative suppliers, assuming commercially reasonable terms could be reached, the challen…

Soligenix, Inc. Customers

Ticker	Name	Confidence	Evidence
SCICLONE-PHARMACEUTICALS-INC	SCICLONE-PHARMACEUTICALS-INC	92%	In September 2016, we and SciClone Pharmaceuticals, Inc. ('SciClone') entered into an exclusive license agreement, pursuant to which we granted rights to SciClone to develop, promote, market, distrib…

Soligenix, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
SNGX-DEBT-12644	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.
SNGX-DEBT-12643	Warrants outstanding: 1.35	90%	xbrl warrant detail from xbrl 2025-12-31.
SNGX-DEBT	Debt stack $358,144	90%	Market cache reports total debt of $358,144.

Soligenix, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Soligenix, Inc..

Soligenix, Inc. Ownership

Holder	Name	Confidence	Evidence
SNGX-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC	GEODE CAPITAL MANAGEMENT, LLC	90%	13F overlay lists GEODE CAPITAL MANAGEMENT, LLC as top holder; 15 tracked holders.

Soligenix, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
GRTXD	Galera Therapeutics, Inc.	100.00	1	['supplier']
IPHYF	Innate Pharma SA	100.00	1	['supplier']

Soligenix, Inc. Supply Chain